References
- Trifonova A, Strateva T. Stenotrophomonas maltophilia – a low-grade pathogen with numerous virulence factors. Infect Dis (Lond). 2019;51(3):168–178.
- Chang YT, Lin CY, Chen YH, et al. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol. 2015;6:893.
- Strateva T, Trifonova A, Savov E, et al. An update on the antimicrobial susceptibility and molecular epidemiology of Stenotrophomonas maltophilia in Bulgaria: a 5-year study (2011–2016). Infect Dis (Lond). 2019;51(5):387–391.
- Afgan E, Baker D, Batut B, et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 2018;46(W1):W537–W544.
- Hu LF, Chen GS, Kong QX, et al. Increase in the prevalence of resistance determinants to trimethoprim/sulfamethoxazole in clinical Stenotrophomonas maltophilia isolates in China. PLoS One. 2016;11(6):e0157693.
- Libisch B, Poirel L, Lepsanovic Z, et al. Identification of PER-1 extended-spectrum beta-lactamase producing Pseudomonas aeruginosa clinical isolates of the international clonal complex CC11 from Hungary and Serbia. FEMS Immunol Med Microbiol. 2008;54(3):330–338.
- Kanamori H, Yano H, Tanouchi A, et al. Prevalence of Smqnr and plasmid-mediated quinolone resistance determinants in clinical isolates of Stenotrophomonas maltophilia from Japan: novel variants of Smqnr. New Microbes New Infect. 2015;7:8–14.
- Flores-Treviño S, Bocanegra-Ibarias P, Camacho-Ortiz A, et al. Stenotrophomonas maltophilia biofilm: its role in infectious diseases. Expert Rev Anti Infect Ther. 2019;17(11):877–893.
- Zhuo C, Zhao QY, Xiao SN. The impact of spgM, rpfF, rmlA gene distribution on biofilm formation in Stenotrophomonas maltophilia. PLoS One. 2014;9(10):e108409.
- Madi H, Lukić J, Vasiljević Z, et al. Genotypic and phenotypic characterization of Stenotrophomonas maltophilia strains from a pediatric tertiary care hospital in Serbia. PLoS One. 2016;11(10):e0165660.